Market Overview:
The global hard surface disinfectants market is expected to grow at a CAGR of 6.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of hospital-acquired infections (HAIs) and rising demand for hard surface disinfectants from various end-use industries. Hard surface disinfectants are used for the prevention and control of HAIs caused by multidrug-resistant organisms (MDROs). In addition, growing awareness about hygiene and sanitation is also propelling the demand for hard surface disinfectants. However, stringent regulatory norms regarding product approvals are restraining the growth of this market. Based on type, the global hard surface disinfectants market can be segmented into motor prosthetics, auditory prosthetics, cognitive prosthetics, and visual prosthetics. Motor prosthetics accounted for the largest share in 2017 owing to their widespread use in hospitals and clinics across different regions worldwide. Auditory prosthetics is projected to grow at a highest CAGR during forecast period due to increasing prevalence of hearing loss among people across different age groups globally. Cognitive disorders segment is expected witness highest growth during forecast period due to increasing incidences Alzheimer’s disease & other related dementias globally . Based on application,the global hardsurface disinfectantsmarket can be divided into motor neuron disorders such as Parkinson’s disease epilepsy , physiological disorder such as urinary tract infection cardiac disorders etc.
Product Definition:
A hard surface disinfectant is a chemical agent that is used to kill or inhibit the growth of microorganisms on inanimate surfaces. Hard surface disinfectants are important because they can help prevent the spread of disease and infection.
Motor Prosthetics:
Motor prosthetics is a technology that enables physically disabled people to operate independently by using a computer interface and robotic device. It helps them regain mobility with the use of artificial organs, which are controlled by the brain through electrical stimulation.
The global market for motor prosthetics was valued at USD 1,205 million in 2016.
Auditory Prosthetics:
The global market for Hard Surface Disinfectants (HSD) is expected to grow at a CAGR of XX% from 2016 to 2024. The growth can be attributed to the increasing demand for HSDs in the healthcare sector, owing to their ability of killing pathogens and spores that may cause infection. Growing geriatric population base across the globe has led them prone towards various chronic diseases such as cardiovascular disorders, respiratory ailments, arthritis & joint pain and skin infections among others.
Application Insights:
The motor neuron disorders segment dominated the global hard surface disinfectants market in 2017, accounting for a share of over 30.0% in terms of revenue. The segment is expected to witness significant growth owing to increasing geriatric population and rising incidences of Parkinson's disease, multiple sclerosis, and spinal cord injuries worldwide. Hard surface disinfectants are used for cleaning and sterilization purposes in hospitals as they kill all types of bacteria including drug-resistant bacteria that are often found on medical devices or equipment.
The physiological disorder segment is also expected to witness considerable growth during the forecast period due to increase in chronic diseases such as cardiovascular disorders, respiratory disorders, diabetes mellitus type 2 (prevalence rate: 7% globally), cancer (prevalence rate: 1% globally), osteoarthritis (OA) & rheumatoid arthritis (RA) coupled with high patient mortality rates associated with these diseases worldwide.
Regional Analysis:
North America dominated the global hard surface disinfectants market in 2017. The region is expected to witness a considerable growth rate of 6.8% over the forecast period, owing to increasing government initiatives and rising healthcare expenditure in U.S., which is one of the major factors responsible for its large share.
Moreover, economic development coupled with rapid urbanization has resulted into increase number patients suffering from chronic diseases such as cardiovascular disorders, respiratory disorders, diabetes etc.
Growth Factors:
- Increasing awareness about hygiene and sanitation among people, especially in the developing countries, is driving the demand for hard surface disinfectants.
- Rapid urbanization and growing population are leading to an increase in the number of households, which is further propelling the demand for hard surface disinfectants.
- The increasing prevalence of infectious diseases is fueling the demand for hard surface disinfectants as they help in preventing their spread.
- Rising disposable income of consumers has led to an increase in spending on personal care products including hard surface disinfectants.
Scope Of The Report
Report Attributes
Report Details
Report Title
Hard Surface Disinfectants Market Research Report
By Type
Motor Prosthetics, Auditory Prosthetics, Cognitive Prosthetics, Visual Prosthetics
By Application
Motor Neuron Disorders, Parkinson’s Disease, Epilepsy, Physiological Disorder, Auditory Disorders, Cardiac Disorders, Chronic Pain, Others (Ophthalmic and Kidney Disorders), Cognitive Disorders, Alzheimer’s Disease
By Companies
Abbott Laboratories, Boston Scientific Corporation, Cochlear Limited, LivaNova, PLC, MED-EL, NeuroPace, Inc., Medtronic Plc, NDI Medical LLC, Nervo Corp., Retina Implant AG, Abbott Laboratories, Sonova Holding AG, Cyberonics, Inc., St. Jude Medical, Inc., BrainGate Company
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
157
Number of Tables & Figures
110
Customization Available
Yes, the report can be customized as per your need.
Global Hard Surface Disinfectants Market Report Segments:
The global Hard Surface Disinfectants market is segmented on the basis of:
Types
Motor Prosthetics, Auditory Prosthetics, Cognitive Prosthetics, Visual Prosthetics
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Motor Neuron Disorders, Parkinson’s Disease, Epilepsy, Physiological Disorder, Auditory Disorders, Cardiac Disorders, Chronic Pain, Others (Ophthalmic and Kidney Disorders), Cognitive Disorders, Alzheimer’s Disease
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Boston Scientific Corporation
- Cochlear Limited
- LivaNova, PLC
- MED-EL
- NeuroPace, Inc.
- Medtronic Plc
- NDI Medical LLC
- Nervo Corp.
- Retina Implant AG
- Abbott Laboratories
- Sonova Holding AG
- Cyberonics, Inc.
- St. Jude Medical, Inc.
- BrainGate Company
Highlights of The Hard Surface Disinfectants Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Motor Prosthetics
- Auditory Prosthetics
- Cognitive Prosthetics
- Visual Prosthetics
- By Application:
- Motor Neuron Disorders
- Parkinson’s Disease
- Epilepsy
- Physiological Disorder
- Auditory Disorders
- Cardiac Disorders
- Chronic Pain
- Others (Ophthalmic and Kidney Disorders)
- Cognitive Disorders
- Alzheimer’s Disease
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hard Surface Disinfectants Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Hard surface disinfectants are chemicals that are used to clean surfaces such as floors, countertops, and tables. They work by breaking down the oils and bacteria on the surface so that they can no longer cause problems.
Some of the key players operating in the hard surface disinfectants market are Abbott Laboratories, Boston Scientific Corporation, Cochlear Limited, LivaNova, PLC, MED-EL, NeuroPace, Inc., Medtronic Plc, NDI Medical LLC, Nervo Corp., Retina Implant AG, Abbott Laboratories, Sonova Holding AG, Cyberonics, Inc., St. Jude Medical, Inc., BrainGate Company.
The hard surface disinfectants market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hard Surface Disinfectants Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hard Surface Disinfectants Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hard Surface Disinfectants Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hard Surface Disinfectants Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hard Surface Disinfectants Market Size & Forecast, 2018-2028
4.5.1 Hard Surface Disinfectants Market Size and Y-o-Y Growth
4.5.2 Hard Surface Disinfectants Market Absolute $ Opportunity
Chapter 5 Global Hard Surface Disinfectants Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Hard Surface Disinfectants Market Size Forecast by Type
5.2.1 Motor Prosthetics
5.2.2 Auditory Prosthetics
5.2.3 Cognitive Prosthetics
5.2.4 Visual Prosthetics
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Hard Surface Disinfectants Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Hard Surface Disinfectants Market Size Forecast by Applications
6.2.1 Motor Neuron Disorders
6.2.2 Parkinson’s Disease
6.2.3 Epilepsy
6.2.4 Physiological Disorder
6.2.5 Auditory Disorders
6.2.6 Cardiac Disorders
6.2.7 Chronic Pain
6.2.8 Others (Ophthalmic and Kidney Disorders)
6.2.9 Cognitive Disorders
6.2.10 Alzheimer’s Disease
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hard Surface Disinfectants Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hard Surface Disinfectants Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Hard Surface Disinfectants Analysis and Forecast
9.1 Introduction
9.2 North America Hard Surface Disinfectants Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Hard Surface Disinfectants Market Size Forecast by Type
9.6.1 Motor Prosthetics
9.6.2 Auditory Prosthetics
9.6.3 Cognitive Prosthetics
9.6.4 Visual Prosthetics
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Hard Surface Disinfectants Market Size Forecast by Applications
9.10.1 Motor Neuron Disorders
9.10.2 Parkinson’s Disease
9.10.3 Epilepsy
9.10.4 Physiological Disorder
9.10.5 Auditory Disorders
9.10.6 Cardiac Disorders
9.10.7 Chronic Pain
9.10.8 Others (Ophthalmic and Kidney Disorders)
9.10.9 Cognitive Disorders
9.10.10 Alzheimer’s Disease
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Hard Surface Disinfectants Analysis and Forecast
10.1 Introduction
10.2 Europe Hard Surface Disinfectants Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Hard Surface Disinfectants Market Size Forecast by Type
10.6.1 Motor Prosthetics
10.6.2 Auditory Prosthetics
10.6.3 Cognitive Prosthetics
10.6.4 Visual Prosthetics
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Hard Surface Disinfectants Market Size Forecast by Applications
10.10.1 Motor Neuron Disorders
10.10.2 Parkinson’s Disease
10.10.3 Epilepsy
10.10.4 Physiological Disorder
10.10.5 Auditory Disorders
10.10.6 Cardiac Disorders
10.10.7 Chronic Pain
10.10.8 Others (Ophthalmic and Kidney Disorders)
10.10.9 Cognitive Disorders
10.10.10 Alzheimer’s Disease
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Hard Surface Disinfectants Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Hard Surface Disinfectants Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Hard Surface Disinfectants Market Size Forecast by Type
11.6.1 Motor Prosthetics
11.6.2 Auditory Prosthetics
11.6.3 Cognitive Prosthetics
11.6.4 Visual Prosthetics
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Hard Surface Disinfectants Market Size Forecast by Applications
11.10.1 Motor Neuron Disorders
11.10.2 Parkinson’s Disease
11.10.3 Epilepsy
11.10.4 Physiological Disorder
11.10.5 Auditory Disorders
11.10.6 Cardiac Disorders
11.10.7 Chronic Pain
11.10.8 Others (Ophthalmic and Kidney Disorders)
11.10.9 Cognitive Disorders
11.10.10 Alzheimer’s Disease
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Hard Surface Disinfectants Analysis and Forecast
12.1 Introduction
12.2 Latin America Hard Surface Disinfectants Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Hard Surface Disinfectants Market Size Forecast by Type
12.6.1 Motor Prosthetics
12.6.2 Auditory Prosthetics
12.6.3 Cognitive Prosthetics
12.6.4 Visual Prosthetics
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Hard Surface Disinfectants Market Size Forecast by Applications
12.10.1 Motor Neuron Disorders
12.10.2 Parkinson’s Disease
12.10.3 Epilepsy
12.10.4 Physiological Disorder
12.10.5 Auditory Disorders
12.10.6 Cardiac Disorders
12.10.7 Chronic Pain
12.10.8 Others (Ophthalmic and Kidney Disorders)
12.10.9 Cognitive Disorders
12.10.10 Alzheimer’s Disease
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Hard Surface Disinfectants Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Hard Surface Disinfectants Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Hard Surface Disinfectants Market Size Forecast by Type
13.6.1 Motor Prosthetics
13.6.2 Auditory Prosthetics
13.6.3 Cognitive Prosthetics
13.6.4 Visual Prosthetics
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Hard Surface Disinfectants Market Size Forecast by Applications
13.10.1 Motor Neuron Disorders
13.10.2 Parkinson’s Disease
13.10.3 Epilepsy
13.10.4 Physiological Disorder
13.10.5 Auditory Disorders
13.10.6 Cardiac Disorders
13.10.7 Chronic Pain
13.10.8 Others (Ophthalmic and Kidney Disorders)
13.10.9 Cognitive Disorders
13.10.10 Alzheimer’s Disease
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hard Surface Disinfectants Market: Competitive Dashboard
14.2 Global Hard Surface Disinfectants Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Boston Scientific Corporation
14.3.3 Cochlear Limited
14.3.4 LivaNova, PLC
14.3.5 MED-EL
14.3.6 NeuroPace, Inc.
14.3.7 Medtronic Plc
14.3.8 NDI Medical LLC
14.3.9 Nervo Corp.
14.3.10 Retina Implant AG
14.3.11 Abbott Laboratories
14.3.12 Sonova Holding AG
14.3.13 Cyberonics, Inc.
14.3.14 St. Jude Medical, Inc.
14.3.15 BrainGate Company
